Top Markets
Coin of the day
Shanxi Zhendong Pharmaceutical Co.,Ltd Shanxi Zhendong Pharmaceutical Co.,Ltd

Shanxi Zhendong Pharmaceutical Co.,Ltd

300158
Rank in Stocks #10982
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages... Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, digestion, urology, and cardio-cerebral drugs. The company also provides Chinese herbal medicines. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is based in Changzhi, China.
Share Price
$0.76514531
Last synced: 2026-08-28
Market Cap
$759.26M
Change (1 day)
0.57%
Change (1 year)
-37.14%
Country
CN
Trade Shanxi Zhendong Pharmaceutical Co.,Ltd (300158)

Category

P/E ratio for Shanxi Zhendong Pharmaceutical Co.,Ltd (300158)
P/E ratio as of 2026 TTM: 0
According to Shanxi Zhendong Pharmaceutical Co.,Ltd latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Shanxi Zhendong Pharmaceutical Co.,Ltd from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.